Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2025 or the PROTECTS Act of 2025
This bill prohibits providing or using federal funds to perform, refer for, or reimburse any entity for certain gender transition procedures for an individual under the age of 18.
The bill’s prohibition applies to certain gender transition procedures that are performed to intentionally change an individual’s body to no longer correspond to the individual's biological sex, including surgeries, medications, and implants specified in the bill. The bill provides exceptions for specified procedures, such as treating certain genetic abnormalities or preventing imminent death or impairment of a major bodily function, when performed by a health care provider with the consent of the individual’s parent or legal guardian.
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 742 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 742
To prohibit Federal funds from being used to provide certain gender
transition procedures to minors.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 28, 2025
Mr. McCormick (for himself, Mr. Clyde, Mrs. Luna, Mr. Scott Franklin of
Florida, Ms. Van Duyne, Mr. Fallon, Mr. Collins, Mr. Weber of Texas,
Mr. Harris of Maryland, Mr. Grothman, Mr. Guest, Mr. Zinke, Mr. Babin,
Mr. Moore of West Virginia, Mr. Ellzey, Mr. Norman, Mr. Webster of
Florida, Mr. Arrington, Mr. Wied, Mr. Rose, Mr. Austin Scott of
Georgia, Mr. Hamadeh of Arizona, Mr. Baird, Mr. Owens, Mr. Gooden, Mr.
Jackson of Texas, Mr. Finstad, Mr. McGuire, Mr. Johnson of South
Dakota, Mr. Ogles, and Mr. Gosar) introduced the following bill; which
was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To prohibit Federal funds from being used to provide certain gender
transition procedures to minors.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Protecting Resources Of Taxpayers to
Eliminate Childhood Transgender Surgeries Act of 2025'' or the
``PROTECTS Act of 2025''.
SEC. 2. PROHIBITING FEDERAL FUNDS FROM BEING USED TO PROVIDE CERTAIN
GENDER TRANSITION PROCEDURES TO MINORS.
(a) In General.--Notwithstanding any other provision of law, no
Federal funds may be used or otherwise made available to provide or
refer for a specified gender transition procedure to an individual
under the age of 18 or to reimburse any entity for providing such a
procedure to such an individual.
(b) Specified Gender Transition Procedure Defined.--
(1) In general.--For purposes of this paragraph, except as
provided in paragraph (2), the term ``specified gender
transition procedure'' means, with respect to an individual,
any of the following when performed for the purpose of
intentionally changing the body of such individual to no longer
correspond to their sex:
(A) Performing any surgery, including--
(i) castration;
(ii) orchiectomy;
(iii) scrotoplasty;
(iv) vasectomy;
(v) hysterectomy;
(vi) oophorectomy;
(vii) ovariectomy;
(viii) metoidioplasty;
(ix) penectomy;
(x) phalloplasty;
(xi) vaginoplasty;
(xii) vaginectomy;
(xiii) vulvoplasty;
(xiv) reduction thyrochondroplasty;
(xv) chondrolaryngoplasty;
(xvi) mastectomy; and
(xvii) any plastic, cosmetic, or aesthetic
surgery that feminizes or masculinizes the
facial or other body features of an individual.
(B) Any placement of chest implants to create
feminine breasts.
(C) Any placement of fat or artificial implants in
the gluteal region.
(D) Administering, supplying, prescribing,
dispensing, distributing, or otherwise conveying to an
individual medications, including--
(i) gonadotropin-releasing hormone (GnRH)
analogues or other puberty-blocking drugs to
stop or delay normal puberty; and
(ii) testosterone, estrogen, or other
androgens to an individual at doses that are
supraphysiologic than would normally be
produced endogenously in a healthy individual
of the same age and sex.
(2) Exception.--Paragraph (1) shall not apply to the
following when furnished to an individual by a health care
provider with the consent of such individual's parent or legal
guardian:
(A) Puberty suppression or blocking prescription
drugs for the purpose of normalizing puberty for an
individual experiencing precocious puberty.
(B) Appropriate and medically necessary procedures
or treatments to correct for--
(i) a medically verifiable genetic disorder
of sex development, including--
(I) 46,XX chromosomes with
virilization;
(II) 46,XY chromosomes with
undervirilization; and
(III) both ovarian and testicular
tissue;
(ii) sex chromosome structure, sex steroid
hormone production, or sex hormone action, if
determined to be abnormal by a physician
through genetic or biochemical testing; or
(iii) infection, disease, injury, or
disorder caused or exacerbated by a previous
procedure described in paragraph (1), or a
physical disorder, physical injury, or physical
illness that would, as certified by a
physician, place the individual in imminent
danger of death or impairment of a major bodily
function unless the procedure is performed, not
including procedures performed for the
alleviation of mental distress.
(3) Certain terms.--For purposes of this section:
(A) Sex.--The term ``sex'', when referring to
individual's sex, shall be understood to refer to
either male or female, as biologically determined.
(B) Female.--The term ``female'', when referring to
a natural person, means an individual who naturally
has, had, will have, or would have, but for a
developmental or genetic anomaly or historical
accident, the reproductive system that at some point
produces, transports, and utilizes eggs for
fertilization.
(C) Male.--The term ``male'', when referring to a
natural person, means an individual who naturally has,
had, will have, or would have, but for a developmental
or genetic anomaly or historical accident, the
reproductive system that at some point produces,
transports, and utilizes sperm for fertilization.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line